The Canadian Glycomics Network (GlycoNet) is a pan-Canadian initiative bringing together over 200 researchers from 37 post-secondary institutions, as well as numerous industry and academic partners, to develop solutions to unmet health needs through the study of glycomics. The network builds on Canada’s international leadership in glycomics over the last 60 years. Glycomics researchers analyze the many roles of carbohydrates (sugars) in biological processes. Glycomics-based research has the potential to lead to the development of new drugs and vaccines for conditions such as influenza, genetic diseases or diabetes. By bringing together all key Canadian glycomics researchers, GlycoNet will deliver novel solutions to important health issues. In this rapidly growing field, the network aims to become a global destination for researchers and industry seeking solutions to problems through applied glycomics research. GlycoNet focuses on 4 research themes: infectious diseases, immunology, precision medicine, animal health and sustainable agri-food systems.
Looking for a particular GlycoNet employee's phone or email?
The GlycoNet annual revenue was $7.5 million in 2026.
Elizabeth Nanak is the CEO of GlycoNet.
9 people are employed at GlycoNet.
GlycoNet is based in Edmonton, Alberta.
The NAICS codes for GlycoNet are [541713, 541, 54171, 54, 5417].
The SIC codes for GlycoNet are [87, 873].